Presentation Information

[28-12-pm05S]RK-582, a tankyrase inhibitor, enhances the antitumor effect of an immune checkpoint inhibitor by remodeling the tumor immune microenvironment

○Ayane Nakamura1,2, Tetsuo Mashima1, Shiho Tsuruta1,3, Xunmei Yuan1, Shun Morino1,3, Fumiyuki Shirai 4, Hiroyuki Seimiya1,2,3 (1. Div. Mol. Biother., Cancer Chemother. Ctr., JFCR., 2. Dept. Life. Pharm. Sci., Grad. Pharm. Sci., Univ. Meiji Pharm., 3. Dept. Comp. Biol. Med. Sci., Grad. Frontier Sci., Univ. Tokyo., 4. Drug Disc. Chem. Platf. Unit, RIKEN Center for Sustainable Res. Sci.)